Valuation: Strides Pharma Science Limited

Market Cap 99.99B 1.05B 945M 882M 799M 1.5B 1.51B 10.58B 4.13B 51.89B 3.94B 3.86B 167B P/E 2027 *
15.9x
P/E 2028 * 11.4x
Enterprise Value 99.99B 1.05B 945M 882M 799M 1.5B 1.51B 10.58B 4.13B 51.89B 3.94B 3.86B 167B EV / Sales 2027 *
1.72x
EV / Sales 2028 * 1.45x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-0.30%
1 week-1.29%
Current month-3.30%
1 month-6.20%
3 months+1.76%
6 months+7.86%
Current year+19.80%
1 week 1,065
Extreme 1065
1,105.4
1 month 1,065
Extreme 1065
1,260.1
Current year 769.6
Extreme 769.6
1,260.1
1 year 769.6
Extreme 769.6
1,260.1
3 years 467.4
Extreme 467.4
1,675.25
5 years 263.45
Extreme 263.45
1,675.25
10 years 263.45
Extreme 263.45
1,675.25
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-1.29% - - 1.05B
+3.62%+1.68%+48.80%+98.41% 1,077B
+2.13%-1.76%+33.04%+61.88% 612B
+3.32%+4.47%+23.72%+91.59% 501B
+3.80%+3.21%+73.99%+41.69% 364B
+0.69%+5.59%+31.08%+47.69% 353B
+1.26%+5.32%+19.17%+42.18% 278B
+1.38%+4.78%-1.46%+13.56% 251B
+3.21%+3.15%+45.01%+49.99% 230B
+3.80%+4.56%+29.59%+97.73% 190B
Average +2.08%+1.97%+33.66%+60.53% 428.5B
Weighted average by Cap. +2.19%+1.58%+37.21%+69.24%

Financials

2027 *2028 *
Net sales 58.23B 612M 550M 513M 465M 874M 879M 6.16B 2.41B 30.22B 2.3B 2.25B 97.2B 69.12B 726M 653M 609M 552M 1.04B 1.04B 7.31B 2.86B 35.88B 2.73B 2.67B 115B
Net income 6.28B 65.96M 59.31M 55.35M 50.16M 94.18M 94.76M 664M 259M 3.26B 248M 242M 10.48B 8.8B 92.45M 83.12M 77.57M 70.3M 132M 133M 931M 363M 4.57B 347M 340M 14.69B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
15/10/26 INR 1,077.10 -0.65% 5,846
14/10/26 INR 1,084.20 -1.26% 5,898
13/10/26 INR 1,098.05 +0.18% 12,451
12/10/26 INR 1,096.05 +1.19% 2,632
09/10/26 INR 1,083.20 -1.09% 9,598
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,084.80INR
Average target price
1,338.67INR
Spread / Average Target
+23.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited